Gene · 51428
Papers1,824
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,824
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Duployez N, Largeaud L, Duchmann M, et al. Prognostic impact of DDX41 germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO study. Blood. 2022;140(7):756-768. | Blood | 2025 | 40674122 | PubTator, text mining | PubMed |
| Expanding the phenotypic spectrum of DDX41-related myeloid neoplasms: a case of mature plasmacytoid dendritic cell proliferation associated with acute myeloid leukemia with germline DDX41 mutation. | Leuk Lymphoma | 2025 | 40658096 | PubTator, text mining | PubMed |
| CSF3R mutations and variants in myeloid neoplasms: associated phenotypes, co-mutations, and survival trends. | Haematologica | 2025 | 40637773 | PubTator, text mining | PubMed |
| Genotype-integrated single-cell transcriptome analysis reveals the role of DDX41 pR525H in a patient with myelodysplastic neoplasms. | Sci Rep | 2025 | 40596075 | PubTator, text mining | PubMed |
| Spliceosomal GTPase EFTUD2 mediates DDX41 intron retention to promote the malignant progression of ovarian cancer. | Br J Cancer | 2025 | 40555777 | PubTator, text mining | PubMed |
| Role of DEAD/DEAH-box helicases in immunity, infection and cancers. | Cell Commun Signal | 2025 | 40537811 | PubTator, text mining | PubMed |
| Structural Changes of Amyloid β-Protein Fibrils on Neuronal Cells. | ACS Chem Neurosci | 2025 | 40493926 | PubTator, text mining | PubMed |
| Broadening the differential diagnosis associated with germline DDX41 mutations. | Haematologica | 2025 | 40438988 | PubTator, text mining | PubMed |
| Clinical Outcome and Molecular Profile in Patients with DDX41 Mutation Hot-Spots. | Hematol Rep | 2025 | 40407636 | PubTator, text mining | PubMed |
| Validation of Guidelines for Genetic Investigation of Myeloid Neoplasms with Germline Predisposition: Results from a Prospective Cohort Study. | Clin Cancer Res | 2025 | 40388595 | PubTator, text mining | PubMed |
| Myelodysplastic syndrome diagnosed by genetic testing for hereditary cancer: a case report. | NPJ Genom Med | 2025 | 40368914 | PubTator, text mining | PubMed |
| Assessment and Improvement of Avatar-Based Learning System: From Linguistic Structure Alignment to Sentiment-Driven Expressions. | Sensors (Basel) | 2025 | 40293090 | PubTator, text mining | PubMed |
| Clinicopathological and prognostic significance of DDX41 mutation in myeloid neoplasms: a systematic review and meta-analysis. | Ann Hematol | 2025 | 40257479 | PubTator, text mining | PubMed |
| A Novel Germline DDX41 Truncating Variant c.24del (p.Lys9Serfs*71): Deleterious Transfer During Related Allogeneic Hematopoietic Stem Cell Transplantation. | Int J Lab Hematol | 2025 | 40176505 | PubTator, text mining | PubMed |
| Diamond-Blackfan anemia syndrome in an adult with RPS19 and DDX41 variants successfully treated with allogeneic stem cell transplantation: a case report. | Leuk Lymphoma | 2025 | 40174221 | PubTator, text mining | PubMed |
| DNA-RNA hybrids in inflammation: sources, immune response, and therapeutic implications. | J Mol Med (Berl) | 2025 | 40131443 | PubTator, text mining | PubMed |
| Who owns that blood? Recontacting donors with results from genetic testing after allogeneic hematopoietic cell transplantation. | Hemasphere | 2025 | 40098897 | PubTator, text mining | PubMed |
| Pathogenic germline variants in cancer predisposition genes in patients with multiple primary cancers in an Asian population and the role of extended panel genetic testing. | ESMO Open | 2025 | 40068381 | PubTator, text mining | PubMed |
| Prevalence of cytopenia(s) and somatic variants in patients with DDX41 mutant germline predisposition syndrome. | Br J Haematol | 2025 | 40040251 | PubTator, text mining | PubMed |
| Overall cancer risk in people with deleterious germline DDX41 variants. | Haematologica | 2025 | 39945023 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51428/papers?page=5